Literature DB >> 4031857

Morphine-induced changes in histamine dynamics in mouse brain.

M Nishibori, R Oishi, Y Itoh, K Saeki.   

Abstract

The effect of the acute morphine treatment on histamine (HA) pools in the brain and the spinal cord was examined in mice. Morphine (1-50 mg/kg, s.c.) administered alone caused no significant change in the steady-state levels of HA and its major metabolite, tele-methylhistamine (t-MH), in the brain. However, depending on the doses tested, morphine significantly enhanced the pargyline (65 mg/kg, i.p.)-induced accumulation of t-MH and this effect was antagonized by naloxone. A specific inhibitor of histidine decarboxylase, alpha-fluoromethylhistidine (alpha-FMH) (50 mg/kg, i.p.), decreased the brain HA level in consequence of the almost complete depletion of the HA pool with a rapid turnover. Morphine further decreased the brain HA level in alpha-FMH-pretreated mice. Morphine administered alone significantly reduced the HA level in the spinal cord, an area where the turnover of HA is very slow. These results suggest that the acute morphine treatment increases the turnover of neuronal HA via opioid receptors, and this opiate also releases HA from a slowly turning over pool(s).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031857     DOI: 10.1111/j.1471-4159.1985.tb04051.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Histamine turnover in the brain of morphine-dependent mice.

Authors:  R Oishi; M Nishibori; Y Itoh; K Saeki; T Fukuda; Y Araki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

2.  The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption.

Authors:  R Suojaranta-Ylinen; H Hendolin; L Tuomisto
Journal:  Agents Actions       Date:  1991-05

3.  Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Erica L Unger; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  J Neurosci Res       Date:  2020-05-19       Impact factor: 4.164

4.  Involvement of central histamine receptors in corticosterone secretion induced by intraventricular administration of morphine.

Authors:  B Cetera; J Bugajski; A Gadek-Michalska
Journal:  Agents Actions       Date:  1988-04

5.  Antagonistic action of naloxone on central histamine receptors-stimulated corticosterone secretion in rats under stress.

Authors:  A Gadek-Michalska; J Bugajski
Journal:  Agents Actions       Date:  1989-11

6.  Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice.

Authors:  M Baba; R Oishi; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

7.  Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice.

Authors:  R Oishi; M Baba; M Nishibori; Y Itoh; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

8.  Effects of halothane, enflurane and pentobarbital on brain histamine dynamics in mice.

Authors:  M Baba; M Nishibori; R Oishi; K Saeki; F Kosaka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

9.  Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice.

Authors:  Y Itoh; R Oishi; M Nishibori; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

10.  Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol.

Authors:  R Oishi; Y Itoh; M Nishibori; K Saeki; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.